Fiona Bruce MP visited a local business to celebrate the focus on their world-leading production of inhalers. 

Fiona, whose Congleton constituency includes Sandbach, visited Holmes Chapel site for Bespak (previously Recipharm) to meet with Louise Righton and Jeremy Tidmarsh along with Chief Executive Officer, Chris Hirst. 

The site is one of three for this organisation leading the way for climate-friendly inhaled and nasal drug-device combination product 

Fiona cut the ribbon, as the Bespak Holmes Chapel branch celebrated the launch of its focus on the production of low Global Warming Potential (GWP) inhalers alongside partnering sites in Kings Lynn and North Carolina, USA. 

"Until now, inhalers have used propellants that are classified as a greenhouse gas," says Fiona. 

"Approximately three per cent of the NHS carbon footprint is on account inhaler emissions, which is more than the health service's travel emissions. 

"This is approximately 13% of the NHS's carbon footprint related to the delivery of care. Bespak are leading the transition to low GWP inhalers becoming the CDMO to manufacture a pressurised metered dose inhalers (pMDIs) with a near-zero global warming potential propellant at a commercial scale. 

"Bespak has also recently announced a significant further investment in manufacturing capacity at its Holmes Chapel site, from which it manufactures a range of leading pMDIs for global pharmaceutical companies." 

The next stage of an extensive expansion plan will enable the installation of commercial-scale and pilot-scale filling lines for the manufacture of pMDIs using HFA-152a, a propellant with a significantly lower Global Warming Potential (GWP) than currently used propellants. 

Jeremy Tidmarsh, site director at Bespak Holmes Chapel said: "As a site, we are driven by our mission to help millions of patients to breathe more easily. 

"We are committed to leading the transition to low-GWP propellants in pMDIs, and in making this investment we become the only pharmaceutical site in the world to have the capability to manufacture at scale with both of the new green propellant options available to the pharmaceutical industry." 

Fiona said: "I was delighted to hear of the innovative work of Bespak at Holmes Chapel, and I'm proud that such a critical health product is being developed here for a worldwide market. 

"As a key local employer for the Congleton constituency, it is hugely encouraging to hear of the globally leading role Bespak is playing in the key transition to supplying life-saving greener inhalers". 

Would you like to know more about Sandbach? 

Free from clickbait, pop-up ads and unwanted surveys, Sandbach Nub News is a quality online newspaper for our town. 

Please consider following Sandbach Nub News on Facebook  or Twitter